151 related articles for article (PubMed ID: 31385224)
1. Regadenoson myocardial perfusion imaging predicts prognosis in patients with either left bundle branch block or a ventricular paced rhythm.
Thomas GS; Taghavi A
J Nucl Cardiol; 2021 Jun; 28(3):978-980. PubMed ID: 31385224
[No Abstract] [Full Text] [Related]
2. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm.
Iskander F; Iskander M; Gomez J; Doukky R
J Nucl Cardiol; 2021 Jun; 28(3):967-977. PubMed ID: 31144225
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging.
Doukky R; Nigatu A; Khan R; Anokwute C; Fughhi I; Ayoub A; Iskander F; Iskander M; Kola S; Sahyouni M; Karavolos K; Hota BN; Gomez J
J Nucl Cardiol; 2020 Oct; 27(5):1521-1532. PubMed ID: 30132187
[TBL] [Abstract][Full Text] [Related]
4. Myocardial blood flow imaging in patients with a left bundle branch block or ventricular-paced rhythm: "And therein, as the Bard would tell us, lies the rub".
Danad I; Knaapen P
J Nucl Cardiol; 2021 Jun; 28(3):989-991. PubMed ID: 33754301
[No Abstract] [Full Text] [Related]
5. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
[TBL] [Abstract][Full Text] [Related]
6. Indirect evidence of sympathetic stimulation by regadenoson.
Farris GR; Hage FG; Kumar V; Iskandrian AE
J Nucl Cardiol; 2019 Apr; 26(2):684-687. PubMed ID: 29948894
[No Abstract] [Full Text] [Related]
7. Initial experience with regadenoson stress positron emission tomography in patients with left bundle branch block: Low prevalence of septal defects and high accuracy for obstructive coronary artery disease.
Meredith D; Cremer PC; Harb SC; Xu B; Mentias A; Jaber WA
J Nucl Cardiol; 2021 Apr; 28(2):536-542. PubMed ID: 30877551
[TBL] [Abstract][Full Text] [Related]
8. Severe myocardial ischemia in a patient with diabetes mellitus and left bundle branch block.
Heindl B; Iskandrian AE; Hage FG
J Nucl Cardiol; 2021 Feb; 28(1):278-288. PubMed ID: 31309462
[TBL] [Abstract][Full Text] [Related]
9. An example of the clinical selectivity of regadenoson for the A2a adenosine receptor.
Miyamoto MI; Clarke KA; Thomas GS; Belardinelli L
Am Heart Hosp J; 2009; 7(2):E118-21. PubMed ID: 20354957
[No Abstract] [Full Text] [Related]
10. Diagnostic accuracy of SPECT and PET myocardial perfusion imaging in patients with left bundle branch block or ventricular-paced rhythm.
Vidula MK; Wiener P; Selvaraj S; Khan MS; Salam UA; Rojulpote C; Metzler SD; Denduluri S; Guerraty M; Julien H; Bravo PE
J Nucl Cardiol; 2021 Jun; 28(3):981-988. PubMed ID: 33083984
[TBL] [Abstract][Full Text] [Related]
11. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
[TBL] [Abstract][Full Text] [Related]
12. Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing.
Katz JS; Ruisi M; Giedd KN; Rachko M
J Nucl Cardiol; 2012 Aug; 19(4):727-34. PubMed ID: 22527801
[TBL] [Abstract][Full Text] [Related]
13. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
[TBL] [Abstract][Full Text] [Related]
14. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
Cerqueira MD; Nguyen P; Staehr P; Underwood SR; Iskandrian AE;
JACC Cardiovasc Imaging; 2008 May; 1(3):307-16. PubMed ID: 19356442
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of regadenoson stress echocardiography: concordance with gated-spect myocardial perfusion imaging.
Iglesias-Garriz I; Vara-Manso J; Sevilla A; Corral F; Lastra JA; RodrÃguez E; Garrote C; Del Castillo S; de la Fuente C; Fernandez-Vazquez F
Int J Cardiovasc Imaging; 2021 Feb; 37(2):509-515. PubMed ID: 32959097
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging.
Lester D; El-Hajj S; Farag AA; Bhambhvani P; Tauxe L; Heo J; Iskandrian AE; Hage FG
J Nucl Cardiol; 2016 Oct; 23(5):1147-1155. PubMed ID: 26490267
[TBL] [Abstract][Full Text] [Related]
17. Lessons from the development of new adenosine A2A receptor agonists.
Udelson JE
JACC Cardiovasc Imaging; 2008 May; 1(3):317-20. PubMed ID: 19356443
[No Abstract] [Full Text] [Related]
18. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.
Partington SL; Lanka V; Hainer J; Blankstein R; Skali H; Forman DE; Di Carli MF; Dorbala S
J Nucl Cardiol; 2012 Oct; 19(5):970-8. PubMed ID: 22565239
[TBL] [Abstract][Full Text] [Related]
19. Predicting left ventricular dyssynchrony: Can nuclear cardiology bring us closer "In Sync"?
Kan K; Phillips LM
J Nucl Cardiol; 2021 Jun; 28(3):1151-1152. PubMed ID: 32548714
[No Abstract] [Full Text] [Related]
20. Capturing maximal coronary vasodilation for myocardial perfusion imaging: is timing everything?
Dilsizian V; Narula J
JACC Cardiovasc Imaging; 2015 Apr; 8(4):499-500. PubMed ID: 25882579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
